Sadaf Farooqi | |
---|---|
Born | Ismaa Sadaf Farooqi |
Alma mater |
|
Known for | Genetics of obesity |
Scientific career | |
Fields | |
Institutions | |
Thesis | Genetics of severe childhood obesity (2001) |
Website | www |
Ismaa Sadaf Farooqi FMedSci FRS is a Wellcome Trust Senior Research fellow [2] in Clinical Science, professor of Metabolism and Medicine at the University of Cambridge and a consultant physician at Addenbrooke's Hospital in Cambridge, UK. [1] [3] [4] [5]
Farooqi was educated at the University of Birmingham where she studied medicine, and was awarded a Bachelor of Medicine, Bachelor of Surgery degree in 1993. [3] After working as a pre-registration house officer and senior house officer, [3] she moved into research and was awarded a PhD in 2001 from the University of Cambridge for research on the genetics of severe childhood obesity. [6] [7]
Farooqi's research investigates the genetics of obesity. [8] [9] [10] [11] Using candidate genes found in patients with severe obesity, her research group have identified patients with mutations in genes encoding leptin, the leptin receptor and biological targets of leptin action, such as the Melanocortin 4 receptor (MC4R). Her group have also demonstrated that the central leptin-melanocortin axis plays a critical role in the regulation of human food intake. [12] [13] Research in her laboratory has shown that people who carry variants of the MC4R gene have an increased preference for high fat food (such as certain recipes of chicken korma), but a decreased preference for sugary foods like Eton mess. [6] [14] [15]
Her research has also proven that mutations in the KSR2 gene are associated with insulin resistance [16] and that genetic variation in the fat mass and obesity-associated protein (FTO) is associated with diminished hunger. [17] Her research has been funded by the Wellcome Trust, [2] [18] Addenbrooke's Charitable Trust and the Framework Programmes for Research and Technological Development (FP7) from the European Union. [3]
Farooqi was elected a Fellow of the Royal Society in 2021. [19]
Farooqi was elected a Fellow of the Academy of Medical Sciences (FMedSci) in 2013. [20] Her citation on election reads:
Sadaf Farooqi has fundamentally altered our understanding of human obesity. Her work was key to the discovery of the first mutations that cause human obesity, defining and characterising a range of previously undescribed genetic obesity syndromes, and establishing that the principal driver of obesity in these monogenic syndromes was a failure of the central control of appetite and satiety. She has been greatly committed to the translation of her research into patient benefit and has helped to change clinical attitudes and diagnostic practice world-wide. Obesity is one of the major public health threats facing the international community and Farooqi's research has been critical in bringing real biological insights where these were previously lacking. [20]
Farooqi was interviewed by Jim Al-Khalili on The Life Scientific , first broadcast on BBC Radio 4 in 2017. [6]
Farooqi was awarded the American Diabetes Association's Outstanding Scientific Achievement Award in 2019. [21]
Pro-opiomelanocortin (POMC) is a precursor polypeptide with 241 amino acid residues. POMC is synthesized in corticotrophs of the anterior pituitary from the 267-amino-acid-long polypeptide precursor pre-pro-opiomelanocortin (pre-POMC), by the removal of a 26-amino-acid-long signal peptide sequence during translation. POMC is part of the central melanocortin system.
Leptin is a protein hormone predominantly made by adipose cells and its primary role is likely to regulate long-term energy balance.
Adipose tissue (also known as body fat, or simply fat) is a loose connective tissue composed mostly of adipocytes. In addition to adipocytes, adipose tissue contains the stromal vascular fraction(SVF) of cells including preadipocytes, fibroblasts, vascular endothelial cells and a variety of immune cells such as adipose tissue macrophages. Adipose tissue is derived from preadipocytes. Its main role is to store energy in the form of lipids, although it also cushions and insulates the body. Far from being hormonally inert, adipose tissue has, in recent years, been recognized as a major endocrine organ, as it produces hormones such as leptin, estrogen, resistin, and cytokines (especially TNFα). In obesity, adipose tissue is also implicated in the chronic release of pro-inflammatory markers known as adipokines, which are responsible for the development of metabolic syndrome, a constellation of diseases, including type 2 diabetes, cardiovascular disease and atherosclerosis. The two types of adipose tissue are white adipose tissue (WAT), which stores energy, and brown adipose tissue (BAT), which generates body heat. The formation of adipose tissue appears to be controlled in part by the adipose gene. Adipose tissue – more specifically brown adipose tissue – was first identified by the Swiss naturalist Conrad Gessner in 1551.
The melanocortins are a family of neuropeptide hormones which are the ligands of the melanocortin receptors The melanocortin system consists of melanocortin receptors, ligands, and accessory proteins. The genes of the melanocortin system are found in chordates. Melanocortins were originally named so because their earliest known function was in melanogenesis. It is now known that the melanocortin system regulates diverse functions throughout the body, including inflammatory response, fibrosis, melanogenesis, steroidogenesis, energy homeostasis, sexual function, and exocrine gland function.
Agouti-signaling protein is a protein that in humans is encoded by the ASIP gene. It is responsible for the distribution of melanin pigment in mammals. Agouti interacts with the melanocortin 1 receptor to determine whether the melanocyte produces phaeomelanin, or eumelanin. This interaction is responsible for making distinct light and dark bands in the hairs of animals such as the agouti, which the gene is named after. In other species such as horses, agouti signalling is responsible for determining which parts of the body will be red or black. Mice with wildtype agouti will be grey, with each hair being partly yellow and partly black. Loss of function mutations in mice and other species cause black fur coloration, while mutations causing expression throughout the whole body in mice cause yellow fur and obesity.
Pseudopseudohypoparathyroidism (PPHP) is an inherited disorder, named for its similarity to pseudohypoparathyroidism in presentation. It is more properly Albright hereditary osteodystrophy although without resistance of parathyroid hormone as frequently seen in that affliction. The term Pseudopseudohypoparathyroidism is used to describe a condition where the individual has the phenotypic appearance of Pseudohypoparathyroidism type 1a, but has normal labs including calcium and PTH.
Fat mass and obesity-associated protein also known as alpha-ketoglutarate-dependent dioxygenase FTO is an enzyme that in humans is encoded by the FTO gene located on chromosome 16. As one homolog in the AlkB family proteins, it is the first mRNA demethylase that has been identified. Certain alleles of the FTO gene appear to be correlated with obesity in humans.
Melanocortin 4 receptor (MC4R) is a melanocortin receptor that in humans is encoded by the MC4R gene. It encodes the MC4R protein, a G protein-coupled receptor (GPCR) that binds α-melanocyte stimulating hormone (α-MSH). In mouse models, MC4 receptors have been found to be involved in feeding behaviour, the regulation of metabolism, sexual behaviour, and male erectile function.
Melanocortin 3 receptor (MC3R) is a protein that in humans is encoded by the MC3R gene.
Single-minded homolog 1, also known as class E basic helix-loop-helix protein 14 (bHLHe14), is a protein that in humans is encoded by the SIM1 gene.
The central melanocortin system is defined anatomically as a collection of central nervous system circuits which include:
RPGRIP1L is a human gene.
Tomas Robert Lindahl FRS FMedSci is a Swedish-British scientist specialising in cancer research. In 2015, he was awarded the Nobel Prize in Chemistry jointly with American chemist Paul L. Modrich and Turkish chemist Aziz Sancar for mechanistic studies of DNA repair.
Like many other medical conditions, obesity is the result of an interplay between environmental and genetic factors. Studies have identified variants in several genes that may contribute to weight gain and body fat distribution; although, only in a few cases are genes the primary cause of obesity.
Sir Stephen Patrick O'Rahilly is an Irish-British physician and scientist known for his research into the molecular pathogenesis of human obesity, insulin resistance and related metabolic and endocrine disorders.
Rudolph Leibel is the Christopher J. Murphy Professor of Diabetes Research, Professor of Pediatrics and Medicine at Columbia University Medical Center, and Director of the Division of Molecular Genetics in the Department of Pediatrics. He is also co-director of the Naomi Berrie Diabetes Center and executive director of the Russell and Angelica Berrie Program in Cellular Therapy, Co-director of the New York Obesity Research Center and the Columbia University Diabetes and Endocrinology Research Center.
Setmelanotide, sold under the brand name Imcivree, is a medication used for the treatment of genetic obesity caused by a rare single-gene mutation.
Vengalil Krishna Kumar Chatterjee is a British endocrinologist. He is a professor of endocrinology in the Department of Medicine at the University of Cambridge and a fellow of Churchill College, Cambridge. He is also the director of the Cambridge Clinical Research Centre, part of the National Institute for Health Research (NIHR).
Pathophysiology of obesity is the study of disordered physiological processes that cause, result from, or are otherwise associated with obesity. A number of possible pathophysiological mechanisms have been identified which may contribute in the development and maintenance of obesity.
Antonio Vidal-Puig is a Spanish medical doctor and scientist who works as a Professor of Molecular Nutrition and Metabolism at the University of Cambridge (UK), best known for advancing the concept that pharmacological targeting of brown fat may serve to treat overweight and obesity in affected individuals, as well as for introducing the concept of adipose tissue "expandability" as an important factor in the pathogenesis of insulin resistance in the context of positive energy balance. His published work focuses on areas such as adipose tissue metabolism and lipotoxicity, regulation of insulin secretion, and the pathophysiology of metabolic syndrome, obesity, and type 2 diabetes.
Is it true that some people put on weight more easily than others? And if so why? It's a question that's close to many of our hearts. And it's a question that medical researcher, Professor Sadaf Farooqi is trying to answer. In 1997, Sadaf noticed that two children she was studying lacked the hormone leptin. From there, she went on to discover the first single gene defect that causes obesity. For most us, how much we eat is within our control. But for children with this rare inherited condition and, it turned out, several other rare genetic disorders, the evidence is clear. A voracious appetite is not a lifestyle choice: it's a biological response to brains signalling starvation. Sadaf tells Jim how she discovered ten rare genetic disorders that cause severe childhood obesity and what this means for the rest of us.